Karyopharm Therapeutics, Inc. (KPTI)

Last Three Months

31-Jan-24 -- 30-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Manufacturers - Major

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

17

0

6

+1

0

+2

0

+3

Two Year Chart

01-May-22 -- 30-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Mar-24 7:38 PM View:	01-Mar-24 Sale ($4.29K)	Mano Michael SVP, General Counsel&Secretary		Karyopharm Therapeutics, Inc. - KPTI	84% 151.4K to 277.85K	0	0	--	--	Show Txns Hide Txns

05-Apr-24 5:20 PM View:	04-Apr-24 Sale ($4.60K)	Paulson Richard A. President and CEO Director		Karyopharm Therapeutics, Inc. - KPTI	40% 825.47K to 1.16M	0	0	--	--	Show Txns Hide Txns

23-Apr-24 4:02 PM View:	22-Apr-24 Sale ($7.94K)	Rangwala Reshma EVP & Chief Medical Officer		Karyopharm Therapeutics, Inc. - KPTI	99% 172.4K to 342.93K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:40 PM View:	01-Mar-24 Sale ($7.39K)	Poulton Stuart EVP, Chief Development Officer		Karyopharm Therapeutics, Inc. - KPTI	94% 169.62K to 329.51K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:39 PM View:	01-Mar-24 Sale ($7.39K)	Mason Michael EVP, CFO & Treasurer		Karyopharm Therapeutics, Inc. - KPTI	59% 251.15K to 398.76K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:37 PM View:	01-Mar-24 Sale ($6.13K)	Cheng Sohanya Roshan EVP & Chief Commercial Officer		Karyopharm Therapeutics, Inc. - KPTI	78% 221.5K to 393.51K	0	0	--	--	Show Txns Hide Txns